CPT code 52265 represents a diagnostic cystoscopy performed under local anesthesia to inspect the urethra, prostatic urethra (in men), bladder interior, and ureteric orifices for evaluation of interstitial cystitis. This procedure is a targeted diagnostic tool that informs clinical management for patients with bladder pain, urinary frequency, or suspected bladder mucosal pathology. Nationally, accurate coding for this procedure matters for appropriate clinical documentation, quality measurement, and claims processing across public and private payers.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for 52265, expected sites of service, and common billing considerations. The publication also outlines benchmarks and policy-relevant points that affect reimbursement and utilization monitoring for cystoscopic evaluations. Clinical teams, coding specialists, and policy analysts will gain clarity on when this diagnostic cystoscopy is used, how it is positioned relative to other bladder evaluation services, and which payer groups commonly cover the service.

Data not available in the input for specific ICD-10 pairings, payer-specific reimbursement rates, and associated taxonomies; those items are noted as unavailable where applicable.